October 10, 2024
October 10, 2024Sam Ajizian, MD (Chief Medical Officer), Jamie Lewis (Chief Commercial Officer), and Laura Spencer Garth (General Counsel) Hired to Advance…
October 1, 2024Sunnyvale, Calif., October 1, 2024 — Inflammatix, a pioneering molecular diagnostics company, today presented data demonstrating the high diagnostic and prognostic…- September 12, 2024
- September 12, 2024
- September 12, 2024
- September 12, 2024Fundraise brings lead product, TriVerity™ Test, closer to commercialization following recent submission to FDA. Sunnyvale, Calif., September 12, 2024 — Inflammatix,…
- January 2, 2024
- November 28, 2023Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage. Sunnyvale, Calif., November 28, 2023 — Inflammatix, Inc., a…
- November 28, 2023
